Arginase-1 Peptide Vaccine in Patients With Metastatic Solid Tumors
收藏NIAID Data Ecosystem2026-03-10 收录
官方服务：
资源简介：
In this phase I first-in-humans-study a vaccine consisting of arginase-1 (ARG1) peptides and the adjuvant Montanide ISA-51 will be tested in ten patients with metastatic solid tumors. Patients will be treated with an ARG1 vaccine every third week for 45 weeks.
创建时间：
2018-12-15
相关数据集
暂无相关数据集
